OPA1 and optic atrophy: Here, we investigated how loss of OPA1 attributed to haploinsufficiency impacts on induced pluripotent stem cell (iPSC)‐derived dopaminergic neurons from patients with syndromic parkinsonism and pure optic atrophy and asked in this tractable model whether specific functions of OPA1 may associate with syndromic disease.